Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phathom Pharmaceuticals

3.14
+0.850037.12%
Post-market: 3.240.1000+3.18%19:59 EDT
Volume:12.64M
Turnover:41.67M
Market Cap:218.70M
PE:-0.60
High:3.78
Open:2.33
Low:2.33
Close:2.29
Loading ...

Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan)

GlobeNewswire
·
31 Mar

Jefferies Cuts Price Target on Phathom Pharmaceuticals to $13 From $17, Maintains Buy Rating

MT Newswires Live
·
20 Mar

Phathom Pharmaceuticals’ Earnings Call: Growth and Challenges

TIPRANKS
·
11 Mar

Phathom Pharmaceuticals Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
11 Mar

Phathom Pharmaceuticals price target lowered to $12 from $18 at Goldman Sachs

TIPRANKS
·
08 Mar

Phathom Pharmaceuticals price target lowered to $18 from $28 at Guggenheim

TIPRANKS
·
07 Mar

Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), Aziyo Biologics (ELUT) and IGM Biosciences (IGMS)

TIPRANKS
·
07 Mar

Phathom Pharmaceuticals: Strategic Positioning and Growth Potential in GERD Market Drives Buy Rating

TIPRANKS
·
07 Mar

Phathom Pharmaceuticals Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
07 Mar

Phathom Pharmaceuticals Inc (PHAT) Q4 2024 Earnings Call Highlights: FDA Approval Boosts ...

GuruFocus.com
·
07 Mar

Phathom Pharmaceuticals Price Target Maintained With a $28.00/Share by Needham

Dow Jones
·
07 Mar

Phathom Pharmaceuticals: Strong Performance and Optimistic Outlook Amidst Patent Uncertainty

TIPRANKS
·
07 Mar

Phathom Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Mar

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
06 Mar

Phathom Pharmaceuticals Q4 Adj $(0.79) Beats $(1.27) Estimate, Sales $29.66M Beat $24.91M Estimate

Benzinga
·
06 Mar

BRIEF-Phathom Pharmaceuticals Q4 Net Income USD -74.451 Million

Reuters
·
06 Mar

Phathom Pharmaceuticals Q4 Net Income USD -74.451 Million

THOMSON REUTERS
·
06 Mar

Phathom Pharmaceuticals Inc Qtrly Adj Shr Loss $0.79

THOMSON REUTERS
·
06 Mar

Phathom Pharmaceuticals Q4 Basic EPS USD -1.05

THOMSON REUTERS
·
06 Mar

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire
·
06 Mar